510(k) K222104
K222104 is an FDA 510(k) premarket notification submitted by Siemens Healthcare Diagnostics, Inc. for the device "Atellica® CH Diazo Total Bilirubin (D_TBil)". The FDA issued a decision of Substantially Equivalent on March 20, 2023. The device falls under product code CIG (Diazo Colorimetry, Bilirubin), a Class II device regulated under 21 CFR 862.1110. Siemens Healthcare Diagnostics, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 20, 2023
- Date Received
- July 18, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Diazo Colorimetry, Bilirubin
- Device Class
- Class II
- Regulation Number
- 862.1110
- Review Panel
- CH
- Submission Type